445
Views
34
CrossRef citations to date
0
Altmetric
Drug Evaluations

Interferon-β treatment for relapsing multiple sclerosis

, MD, &
Pages 1435-1447 | Published online: 11 Aug 2008
 

Abstract

Background: Recombinant forms of IFN-β were the first therapeutic intervention found to be effective at interfering with the course of multiple sclerosis (MS), a chronic and debilitating disease affecting the CNS in young adults. Objective/methods: To examine the application of IFN-β to MS treatment by a review of relevant literature. Results: The different IFN-β products available are similar in their clinical effects. However, the response to IFN-β therapy is only partial and the most efficient individual-specific dose, route and frequency of administration are not elucidated fully. The mechanism of action of IFN-β in MS is also not understood fully but its immunomodulatory effects are probably more important than its anti-proliferative and antiviral activities. Conclusions: Although new therapeutic approaches are being sought to better treat MS, IFN-β remains one of the most recognized and approved worldwide therapeutic options for this disease.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.